According to the American Diabetes Association, more than 34 million Americans live with diabetes. On average, the cost of medical expenses for people with diagnosed diabetes is approximately 2.3 ...
Add Yahoo as a preferred source to see more of our stories on Google. When a clinician prescribes a medication for a purpose for which its not indicated by the U.S. Food and Drug Administration (FDA), ...
Tandem Diabetes Care, Insulet and Dexcom all presented data over the weekend at the American Diabetes Association’s ...
Tandem Diabetes Care (TNDM) stock is in focus as the EU grants CE mark expanding the indications for its automated insulin ...
After nearly seven months and two prior recalls, Viatris continues to be vexed by labeling issues on its biosimilar to Sanofi’s diabetes blockbuster Lantus. Viatris’ Mylan this week said it was once ...
In a move aimed at expanding affordable treatment options for millions of Americans living with diabetes, Biocon Biologics Ltd. and nonprofit generic drug manufacturer Civica, Inc. have announced a ...
The recalled product does not pertain to the branded interchangeable biosimilar, Semglee (insulin glargine-yfgn). Mylan Pharmaceuticals has voluntarily recalled 1 batch of Insulin Glargine (insulin ...
CHICAGO, June 29 (Reuters) - Walmart (WMT.N), opens new tab said on Tuesday that it will start selling private-label analog insulin this week at a deep discount to branded insulin vials and pens, as ...
Credit: Getty Images. The recall does not pertain to the interchangeable biosimilars, Semglee (insulin glargine-yfgn) injection, or Insulin Glargine (insulin glargine-yfgn) injection. Mylan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results